Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients

NCT01394835 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Lung Transplantation
Bronchiolitis Obliterable Syndrome

Interventions

DRUG: Alpha -1 Antitrypsin
DRUG: Alpha-1 Antitrypsin
DRUG: AAT

Sponsor

Rabin Medical Center